Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Fusahiro Higashitani is active.

Publication


Featured researches published by Fusahiro Higashitani.


European Journal of Medicinal Chemistry | 1998

Synthesis and antibacterial activity of 7-hydrazinoquinolones

Rajeshwar Singh; Rakhshandeh Fathi-Afshar; George Thomas; Maya P. Singh; Fusahiro Higashitani; Akio Hyodo; Norio Unemi; Ronald G. Micetich

A series of new C-7 substituted hydrazino quinolones and naphthyridines were prepared and tested for antibacterial activity. The hydrazine bridge at the C-7 position did not favor the antibacterial activity, whereas the nature of other substituents at N-1, C-5 and C-8 did noticeably influence the antibacterial activity. The 7-(1-aminomorpholino) derivatives exhibited superior antibacterial activity against Gram-positive and inferior activity against Gram-negative bacteria than the 7-(1-aminopiperazinyl) derivatives. Substitution of the quinolone at position-1 with cyclopropyl was the most beneficial for antibacterial activity among the series of compounds prepared.


Chemotherapy | 1997

Superior Effect of Tazobactam/ Piperacillin Compared to Piperacillin on β-Lactamase-Producing Pseudomonas aeruginosa

Kouichi Nishida; Fusahiro Higashitani; Akio Hyodo

To evaluate the synergistic antimicrobial effects of tazobactam (TAZ), a beta-lactamase inhibitor, and piperacillin (PIPC) on Pseudomonas aeruginosa, we compared the antimicrobial effects of TAZ/PIPC with those of PIPC alone on bacteria inducibly or constitutively producing beta-lactamase. TAZ/PIPC had more potent antimicrobial effects compared with PIPC on clinical isolates producing beta-lactamase. In the treatment of mouse systemic infection, the therapeutic effect of PIPC was markedly decreased by beta-lactamase, but that of TAZ/PIPC was only slightly decreased. In the treatment of local infections in mice, the therapeutic effects of PIPC were decreased due to the induction of beta-lactamase and the emergence of bacterial strains constitutively producing beta-lactamase, while those of TAZ/ PIPC were not affected.


Antimicrobial Agents and Chemotherapy | 1999

In Vitro and In Vivo Activities of Syn2190, a Novel β-Lactamase Inhibitor

Kouichi Nishida; Chieko Kunugita; Tatsuya Uji; Fusahiro Higashitani; Akio Hyodo; Norio Unemi; Samarendra N. Maiti; Oludotun A. Phillips; Paul Spevak; Kevin Atchison; Sameeh Salama; Harninder Atwal; Ronald G. Micetich


Journal of Antimicrobial Chemotherapy | 1990

Inhibition of β-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin

Fusahiro Higashitani; Akio Hyodo; Naofumi Ishida; Matsuhisa Inoue; Susumu Mitsuhashi


Archive | 1997

AZETIDINONE DERIVATIVES AS β-LACTAMASE INHIBITORS

Samarendra N. Maiti; Oludotun A. Phillips; Eduardo L. Setti; Andhe V. Narender Reddy; Ronald G. Micetich; Fusahiro Higashitani; Chieko Kunugita; Koichi Nishida; Tatsuya Uji


The Journal of Antibiotics | 1995

Effects of Tazobactam on the Frequency of the Emergence of Resistant Strains from Enterobacter cloacae, Citrobacter freundii, and Proteus vulgaris (β-Lactamase Derepressed Mutants)

Fusahiro Higashitani; Kouichi Nishida; Akio Hyodo; Matsuhisa Inoue


Archive | 1998

2-oxo-1-azetidine sulfonic acid derivatives as potent beta-lactamase inhibitors

Samarendra N. Maiti; Eduardo L. Setti; Oludotun A. Phillips; Andhe V. Narender Reddy; Ronald G. Micetich; Rajeshwar Singh; Fusahiro Higashitani; Chieko Kunugita; Koichi Nishida; Tatsuya Uji


Archive | 1996

Novel penam sulfones as beta-lactamase inhibitors

Fusahiro Higashitani; Akio Hyodo; Chieko Kunugita; Samarendra N. Maiti; Ronald G. Micetich; Oludotun A. Phillips; Andhe V. Narender Reddy; Eduardo L. Setti


The Journal of Antibiotics | 1995

Characterization of a New Plasmid-mediated Extended-spectrum β-Lactamase from Serratia marcescens

Chieko Kunugita; Fusahiro Higashitani; Akio Hyodo; Norio Unemi; Matsuhisa Inoue


Archive | 1995

Penam sulfones as beta -lactamase inhibitors

Samarendra N. Maiti; Oludotun A. Phillips; Andhe V. Narender Reddy; Eduardo L. Setti; Ronald G. Micetich; Chieko Kunugita; Fusahiro Higashitani; Akio Hyodo

Collaboration


Dive into the Fusahiro Higashitani's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rajeshwar Singh

National Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge